Cargando…

Circulating Insulin-Like Growth Factor 1–Related Biomarkers and Risk of Lethal Prostate Cancer

BACKGROUND: Experimental and epidemiologic evidence supports the role of circulating insulin-like growth factor-1 (IGF-1) levels with the risk of prostate cancer. Most circulating IGF-1 is bound to specific binding proteins, and only about 5% circulates in a free form. We explored the relation of fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Chaoran, Wang, Ye, Wilson, Kathryn M, Mucci, Lorelei A, Stampfer, Meir J, Pollak, Michael, Penney, Kathryn L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763370/ https://www.ncbi.nlm.nih.gov/pubmed/35047751 http://dx.doi.org/10.1093/jncics/pkab091

Ejemplares similares

Addition of a Genetic Risk Score for Identification of Men with a Low Prostate-specific Antigen Level in Midlife at Risk of Developing Lethal Prostate Cancer
por: Ma, Chaoran, et al.
Publicado: (2023)

DNA Repair Pathways and Their Association With Lethal Prostate Cancer in African American and European American Men
por: Plym, Anna, et al.
Publicado: (2021)

Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts
por: Wolpin, B M, et al.
Publicado: (2007)

Replication of a Genetic Variant for Prostate Cancer-Specific Mortality
por: Penney, Kathryn L., et al.
Publicado: (2015)

Evaluation of a Multiethnic Polygenic Risk Score Model for Prostate Cancer
por: Plym, Anna, et al.
Publicado: (2021)

A Prospective Study of Plasma Vitamin D Metabolites, Vitamin D Receptor Polymorphisms, and Prostate Cancer
por: Li, Haojie, et al.
Publicado: (2007)

Germline Variation in Superoxide Dismutase-2 (SOD2) and Survival Outcomes after Radiation Therapy for Prostate Cancer: Results from a Test and Validation Set Analysis
por: Margalit, Danielle N., et al.
Publicado: (2015)

Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia.
por: Mantzoros, C. S., et al.
Publicado: (1997)

The prostate tissue‐based telomere biomarker as a prognostic tool for metastasis and death from prostate cancer after prostatectomy
por: Heaphy, Christopher M, et al.
Publicado: (2022)

Prediagnostic Plasma Vitamin D Metabolites and Mortality among Patients with Prostate Cancer
por: Fang, Fang, et al.
Publicado: (2011)

Family History of Prostate and Breast Cancer Integrated with a Polygenic Risk Score Identifies Men at Highest Risk of Dying from Prostate Cancer before Age 75 Years
por: Plym, Anna, et al.
Publicado: (2022)

Clinical stage provides useful prognostic information even after pathological stage is known for prostate cancer in the PSA era
por: Chen, Maxine M., et al.
Publicado: (2020)

Immediate Risk for Cardiovascular Events and Suicide Following a Prostate Cancer Diagnosis: Prospective Cohort Study
por: Fall, Katja, et al.
Publicado: (2009)

Post-diagnostic health behaviour scores in relation to fatal prostate cancer
por: Graff, Rebecca E., et al.
Publicado: (2022)

Stromal and epithelial transcriptional map of initiation progression and metastatic potential of human prostate cancer
por: Tyekucheva, Svitlana, et al.
Publicado: (2017)

The association between neighborhood greenness and incidence of lethal prostate cancer: A prospective cohort study
por: Iyer, Hari S., et al.
Publicado: (2020)

Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis
por: Watts, Eleanor L, et al.
Publicado: (2022)

Analysis of the 10q11 Cancer Risk Locus Implicates MSMB and NCOA4 in Human Prostate Tumorigenesis
por: Pomerantz, Mark M., et al.
Publicado: (2010)

Total antioxidant intake and prostate cancer in the Cancer of the Prostate in Sweden (CAPS) study. A case control study
por: Russnes, Kjell M., et al.
Publicado: (2016)

Promoting Reproducibility and Integrity in Observational Research: One Approach of an Epidemiology Research Community
por: Stopsack, Konrad H., et al.
Publicado: (2023)

Plasma Biomarkers of Insulin and the Insulin-like Growth Factor Axis, and Risk of Colorectal Adenoma and Serrated Polyp
por: Hang, Dong, et al.
Publicado: (2019)

Consumption of Fish Products across the Lifespan and Prostate Cancer Risk
por: Torfadottir, Johanna E., et al.
Publicado: (2013)

Interactions of the Insulin-Like Growth Factor Axis and Vitamin D in Prostate Cancer Risk in the Prostate Cancer Prevention Trial
por: Miles, Fayth L., et al.
Publicado: (2017)

Pre-diagnostic circulating sex hormone levels and risk of prostate cancer by ERG tumour protein expression
por: Graff, Rebecca E, et al.
Publicado: (2016)

Gut Microbiome–Dependent Metabolic Pathways and Risk of Lethal Prostate Cancer: Prospective Analysis of a PLCO Cancer Screening Trial Cohort
por: Reichard, Chad A., et al.
Publicado: (2022)

Effects of G/A polymorphism, rs266882, in the androgen response element 1 of the PSA gene on prostate cancer risk, survival and circulating PSA levels
por: Jesser, C, et al.
Publicado: (2008)

Extent, impact, and mitigation of batch effects in tumor biomarker studies using tissue microarrays
por: Stopsack, Konrad H, et al.
Publicado: (2021)

Insulin-like growth factors and risk of kidney cancer in men
por: Major, J M, et al.
Publicado: (2010)

Protegrin 1 Enhances Innate Cellular Defense via the Insulin-Like Growth Factor 1 Receptor Pathway
por: Penney, Jenna, et al.
Publicado: (2018)

Effect of insulin-like growth factor system on luteinising angiogenesis
por: Nwachukwu, Chinwe U, et al.
Publicado: (2023)

Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and lobule type in the Nurses' Health Study II
por: Rice, Megan S, et al.
Publicado: (2012)

The neglected role of insulin-like growth factors in the maternal circulation regulating fetal growth
por: Sferruzzi-Perri, A N, et al.
Publicado: (2011)

Circulating insulin-like growth factor I modulates mood and is a biomarker of vulnerability to stress: from mouse to man
por: Santi, A., et al.
Publicado: (2018)

Similarity of Serum and Plasma Insulin-like Growth Factor Concentrations
por: Houghton, Lauren C, et al.
Publicado: (2015)

Zinc supplement use and risk of aggressive prostate cancer: a 30-year follow-up study
por: Zhang, Yiwen, et al.
Publicado: (2022)

Insulin-like growth factors and liver cancer risk in male smokers
por: Major, J M, et al.
Publicado: (2010)

Molecular sampling of prostate cancer: a dilemma for predicting disease progression
por: Sboner, Andrea, et al.
Publicado: (2010)

Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia.
por: Cohen, P., et al.
Publicado: (1998)

The role of tumor metabolism as a driver of prostate cancer progression and lethal disease: results from a nested case-control study
por: Kelly, Rachel S., et al.
Publicado: (2016)

Identification of serum insulin-like growth factor binding protein 1 as diagnostic biomarker for early-stage alcohol-induced liver disease
por: Li, Heng-Hong, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3l9vm9rcttnl0qnvodptfap9lg